NCT05882591 Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
| NCT ID | NCT05882591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Artromedical Konrad Malinowski Clinic |
| Condition | Meniscus Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2020-10-09 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2020-10-09 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess outcomes of Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
Eligibility Criteria
Inclusion Criteria: * Pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat * Reduced concavity of the femoral metaphysis proximal to the medial femoral condyle confirmed on MRI * Impingement of posterior horn of medial meniscus with the metaphysis of femur during full knee flexion confirmed arthroscopically Exclusion Criteria: * Active knee inflammation * Chondral injuries ICRS 3-4 * Extraarticular reasons of pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat * Cyst or avascular changes within the femoral metaphysis adjacent to the planned localization of the procedure
Contact & Investigator
Konrad Malinowski, MD PhD
PRINCIPAL INVESTIGATOR
Artromedical Orthopaedic Clinic, Bełchatów, Poland
Frequently Asked Questions
Who can join the NCT05882591 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Meniscus Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05882591 currently recruiting?
Yes, NCT05882591 is actively recruiting participants. Contact the research team at malwin8@wp.pl for enrollment information.
Where is the NCT05882591 trial being conducted?
This trial is being conducted at Bełchatów, Poland.
Who is sponsoring the NCT05882591 clinical trial?
NCT05882591 is sponsored by Artromedical Konrad Malinowski Clinic. The principal investigator is Konrad Malinowski, MD PhD at Artromedical Orthopaedic Clinic, Bełchatów, Poland. The trial plans to enroll 10 participants.